Bloomberg: Intrivo CEO on CareStart™ EUA approvals

August 12, 2020
You might also like
Intrivo's distinctive culture underlies success based on the Sapient Leadership framework
Medium calls Sniffles "Everything You Need When You Get Sick"
On/go for\Good leads donations that enable opening of new children's mental health center in Ukraine

Reeve Benaron, chairman and interim chief executive officer at Intrivo, discusses the U.S. Food and Drug Administration’s emergency use authorization of a Covid-19 antigen test the company distributes for Access Bio. Benaron speaks with Bloomberg’s Emily Chang. (Source: Bloomberg)